Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells.

Saved in:
Bibliographic Details
Title: Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells.
Authors: Trabelsi MS; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Daoudi M; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Prawitt J; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Ducastel S; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Touche V; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Sayin SI; Wallenberg Laboratory/Sahlgrenska Center for Cardiovascular and Metabolic Research, Sahlgrenska University Hospital, Gothenburg 413445, Sweden.; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg 41345, Sweden., Perino A; Institute of Bioengineering, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne CH-1015, Switzerland., Brighton CA; Cambridge Institute for Medical Research and Institute of Metabolic Sciences, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0XY, UK., Sebti Y; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Kluza J; Université de Lille, Lille F-59000, France.; INSERM U 837, Lille Cedex F- 59045, France., Briand O; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Dehondt H; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Vallez E; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Dorchies E; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Baud G; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; Centre de Bio-Pathologie, Plate-forme de Biothérapie, Banque de Tissus, Centre Hospitalier Régional Universitaire, Lille F-59000, France.; INSERM UMR 859, Lille F-59000, France., Spinelli V; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Hennuyer N; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Caron S; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Bantubungi K; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Caiazzo R; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; Centre de Bio-Pathologie, Plate-forme de Biothérapie, Banque de Tissus, Centre Hospitalier Régional Universitaire, Lille F-59000, France.; INSERM UMR 859, Lille F-59000, France., Reimann F; Cambridge Institute for Medical Research and Institute of Metabolic Sciences, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0XY, UK., Marchetti P; Université de Lille, Lille F-59000, France.; INSERM U 837, Lille Cedex F- 59045, France., Lefebvre P; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Bäckhed F; Wallenberg Laboratory/Sahlgrenska Center for Cardiovascular and Metabolic Research, Sahlgrenska University Hospital, Gothenburg 413445, Sweden.; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg 41345, Sweden.; Section for Metabolic Receptology and Enteroendocrinology, Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health Sciences, University of Copenhagen, Copenhagen 2200, Denmark., Gribble FM; Cambridge Institute for Medical Research and Institute of Metabolic Sciences, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0XY, UK., Schoonjans K; Institute of Bioengineering, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne CH-1015, Switzerland., Pattou F; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; Centre de Bio-Pathologie, Plate-forme de Biothérapie, Banque de Tissus, Centre Hospitalier Régional Universitaire, Lille F-59000, France.; INSERM UMR 859, Lille F-59000, France., Tailleux A; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Staels B; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France., Lestavel S; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France.
Source: Nature communications [Nat Commun] 2015 Jul 02; Vol. 6, pp. 7629. Date of Electronic Publication: 2015 Jul 02.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 26134028
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Trabelsi+MS%22">Trabelsi MS</searchLink>; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France.<br /><searchLink fieldCode="AU" term="%22Daoudi+M%22">Daoudi M</searchLink>; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France.<br /><searchLink fieldCode="AU" term="%22Prawitt+J%22">Prawitt J</searchLink>; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France.<br /><searchLink fieldCode="AU" term="%22Ducastel+S%22">Ducastel S</searchLink>; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France.<br /><searchLink fieldCode="AU" term="%22Touche+V%22">Touche V</searchLink>; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France.<br /><searchLink fieldCode="AU" term="%22Sayin+SI%22">Sayin SI</searchLink>; Wallenberg Laboratory/Sahlgrenska Center for Cardiovascular and Metabolic Research, Sahlgrenska University Hospital, Gothenburg 413445, Sweden.; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg 41345, Sweden.<br /><searchLink fieldCode="AU" term="%22Perino+A%22">Perino A</searchLink>; Institute of Bioengineering, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne CH-1015, Switzerland.<br /><searchLink fieldCode="AU" term="%22Brighton+CA%22">Brighton CA</searchLink>; Cambridge Institute for Medical Research and Institute of Metabolic Sciences, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0XY, UK.<br /><searchLink fieldCode="AU" term="%22Sebti+Y%22">Sebti Y</searchLink>; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France.<br /><searchLink fieldCode="AU" term="%22Kluza+J%22">Kluza J</searchLink>; Université de Lille, Lille F-59000, France.; INSERM U 837, Lille Cedex F- 59045, France.<br /><searchLink fieldCode="AU" term="%22Briand+O%22">Briand O</searchLink>; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France.<br /><searchLink fieldCode="AU" term="%22Dehondt+H%22">Dehondt H</searchLink>; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France.<br /><searchLink fieldCode="AU" term="%22Vallez+E%22">Vallez E</searchLink>; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France.<br /><searchLink fieldCode="AU" term="%22Dorchies+E%22">Dorchies E</searchLink>; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France.<br /><searchLink fieldCode="AU" term="%22Baud+G%22">Baud G</searchLink>; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; Centre de Bio-Pathologie, Plate-forme de Biothérapie, Banque de Tissus, Centre Hospitalier Régional Universitaire, Lille F-59000, France.; INSERM UMR 859, Lille F-59000, France.<br /><searchLink fieldCode="AU" term="%22Spinelli+V%22">Spinelli V</searchLink>; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France.<br /><searchLink fieldCode="AU" term="%22Hennuyer+N%22">Hennuyer N</searchLink>; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France.<br /><searchLink fieldCode="AU" term="%22Caron+S%22">Caron S</searchLink>; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France.<br /><searchLink fieldCode="AU" term="%22Bantubungi+K%22">Bantubungi K</searchLink>; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France.<br /><searchLink fieldCode="AU" term="%22Caiazzo+R%22">Caiazzo R</searchLink>; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; Centre de Bio-Pathologie, Plate-forme de Biothérapie, Banque de Tissus, Centre Hospitalier Régional Universitaire, Lille F-59000, France.; INSERM UMR 859, Lille F-59000, France.<br /><searchLink fieldCode="AU" term="%22Reimann+F%22">Reimann F</searchLink>; Cambridge Institute for Medical Research and Institute of Metabolic Sciences, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0XY, UK.<br /><searchLink fieldCode="AU" term="%22Marchetti+P%22">Marchetti P</searchLink>; Université de Lille, Lille F-59000, France.; INSERM U 837, Lille Cedex F- 59045, France.<br /><searchLink fieldCode="AU" term="%22Lefebvre+P%22">Lefebvre P</searchLink>; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France.<br /><searchLink fieldCode="AU" term="%22Bäckhed+F%22">Bäckhed F</searchLink>; Wallenberg Laboratory/Sahlgrenska Center for Cardiovascular and Metabolic Research, Sahlgrenska University Hospital, Gothenburg 413445, Sweden.; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg 41345, Sweden.; Section for Metabolic Receptology and Enteroendocrinology, Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health Sciences, University of Copenhagen, Copenhagen 2200, Denmark.<br /><searchLink fieldCode="AU" term="%22Gribble+FM%22">Gribble FM</searchLink>; Cambridge Institute for Medical Research and Institute of Metabolic Sciences, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0XY, UK.<br /><searchLink fieldCode="AU" term="%22Schoonjans+K%22">Schoonjans K</searchLink>; Institute of Bioengineering, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne CH-1015, Switzerland.<br /><searchLink fieldCode="AU" term="%22Pattou+F%22">Pattou F</searchLink>; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; Centre de Bio-Pathologie, Plate-forme de Biothérapie, Banque de Tissus, Centre Hospitalier Régional Universitaire, Lille F-59000, France.; INSERM UMR 859, Lille F-59000, France.<br /><searchLink fieldCode="AU" term="%22Tailleux+A%22">Tailleux A</searchLink>; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France.<br /><searchLink fieldCode="AU" term="%22Staels+B%22">Staels B</searchLink>; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France.<br /><searchLink fieldCode="AU" term="%22Lestavel+S%22">Lestavel S</searchLink>; European Genomic Institute for Diabetes (EGID), FR 3508, Lille F-59000, France.; Université de Lille, Lille F-59000, France.; INSERM UMR 1011, Lille F-59000, France.; Institut Pasteur de Lille, Lille F-59000, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2015 Jul 02; Vol. 6, pp. 7629. <i>Date of Electronic Publication: </i>2015 Jul 02.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=26134028
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/ncomms8629
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 7629
    Titles:
      – TitleFull: Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Trabelsi MS
      – PersonEntity:
          Name:
            NameFull: Daoudi M
      – PersonEntity:
          Name:
            NameFull: Prawitt J
      – PersonEntity:
          Name:
            NameFull: Ducastel S
      – PersonEntity:
          Name:
            NameFull: Touche V
      – PersonEntity:
          Name:
            NameFull: Sayin SI
      – PersonEntity:
          Name:
            NameFull: Perino A
      – PersonEntity:
          Name:
            NameFull: Brighton CA
      – PersonEntity:
          Name:
            NameFull: Sebti Y
      – PersonEntity:
          Name:
            NameFull: Kluza J
      – PersonEntity:
          Name:
            NameFull: Briand O
      – PersonEntity:
          Name:
            NameFull: Dehondt H
      – PersonEntity:
          Name:
            NameFull: Vallez E
      – PersonEntity:
          Name:
            NameFull: Dorchies E
      – PersonEntity:
          Name:
            NameFull: Baud G
      – PersonEntity:
          Name:
            NameFull: Spinelli V
      – PersonEntity:
          Name:
            NameFull: Hennuyer N
      – PersonEntity:
          Name:
            NameFull: Caron S
      – PersonEntity:
          Name:
            NameFull: Bantubungi K
      – PersonEntity:
          Name:
            NameFull: Caiazzo R
      – PersonEntity:
          Name:
            NameFull: Reimann F
      – PersonEntity:
          Name:
            NameFull: Marchetti P
      – PersonEntity:
          Name:
            NameFull: Lefebvre P
      – PersonEntity:
          Name:
            NameFull: Bäckhed F
      – PersonEntity:
          Name:
            NameFull: Gribble FM
      – PersonEntity:
          Name:
            NameFull: Schoonjans K
      – PersonEntity:
          Name:
            NameFull: Pattou F
      – PersonEntity:
          Name:
            NameFull: Tailleux A
      – PersonEntity:
          Name:
            NameFull: Staels B
      – PersonEntity:
          Name:
            NameFull: Lestavel S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 07
              Text: 2015 Jul 02
              Type: published
              Y: 2015
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 6
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1